BAHLIS, Nizar J
$522,880.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2013-2014
Canada
Bortezomib mediated BRCAness in Myeloma cells: novel therapeutic approach combining PARP1-2 and 26S proteasome inhibitors.